Olink Proteomics is a rapidly growing life science company committed to advancing the understanding of human diseases through proteomics. We are dedicated to innovation, quality, rigor and transparency, providing outstanding solutions and support for human protein biomarker discovery.
The vital role of proteins in understanding human biology has been recognized for many decades, but technological limitations severely restricted the comprehensive investigation of the huge number of proteins that could be important in different biological processes and diseases. With Olink, scientists can now simultaneously measure thousands of human proteins using just a few µL of blood sample, with highly specific, thoroughly validated assays that cover a very wide dynamic range (fg/mL to µg/mL).
In a few years, Olink has grown rapidly from a small, Sweden-based company offering assays for a few hundred proteins, to a NASDAQ-listed organization with a strong global presence, a broad portfolio of flexible protein biomarker solutions and library of high quality, thoroughly validated assays that covers ~3000 proteins.